Zobrazeno 1 - 10
of 213
pro vyhledávání: '"D J, Wright"'
Publikováno v:
Pharmacy, Vol 12, Iss 2, p 65 (2024)
The aim of this study was to describe the opinions of patients undergoing treatment with originator biologics and medical consultants managing their conditions and identify the barriers and enablers to transitioning from originator biologics to equiv
Externí odkaz:
https://doaj.org/article/e77ec9a41fdd4ea0aebba7a36bdeeed0
Autor:
L. Birt, L. Dalgarno, C. M. Bond, R. Holland, D. P. Alldred, C. Hughes, A. Blyth, L. Watts, D. J. Wright, on behalf of the CHIPPS team
Publikováno v:
BMC Medical Education, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The provision of independent prescribing rights for United Kingdom (UK) pharmacists has enabled them to prescribe within their area of competence. The aim of this study was to evaluate an evidence-based training programme designed
Externí odkaz:
https://doaj.org/article/06ebb1eabf2a48d987a3a1756aced5e8
Autor:
G. Biolcatti, S. Hanneken, E. I. Minder, N. J. Neumann, J. H. P. Wilson, P. J. Wolgen, D. J. Wright, A. J. Lloyd
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract Background A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the benefit of treatment, a novel patient re
Externí odkaz:
https://doaj.org/article/2c9d15ce8ed5409c8a84cc284a18d928
Autor:
G. Biolcati, S. Hanneken, E. I. Minder, N. J. Neumann, J. H. P. Wilson, P. J. Wolgen, D. J. Wright, A. J. Lloyd
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/cb1acc0b1eae4ac1909d03cda7e83123
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Introduction Zio XT is a recent technology that has enabled automated heart rhythm analysis using an artificial intelligence-based algorithm. It can be fitted by patients and record the heart rh
Autor:
J A De Veld, P P H M Delnoy, L R A Olde Nordkamp, J Kuschyk, H Bonnemeier, N R Bijsterveld, L V A Boersma, M F El Chami, L Smeding, A Weger, S Richter, T R Betts, D J Wright, A A M Wilde, R E Knops
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific Medical device company St. Paul, Minnesota, USA Introduction The PRAETORIAN trial showed that the subcutaneous implantabl
Publikováno v:
European Heart Journal. 43
Introduction The Zio XT is an adhesive, ambulatory heart rhythm monitoring device that can be worn for up to 14 days. It can be fitted by patients and utilises an Artificial Intelligence-based algorithm for rhythm analysis, offering potential conveni
Autor:
Fabo Feng, R. Paul Butler, Steven S. Vogt, Matthew S. Clement, C. G. Tinney, Kaiming Cui, Masataka Aizawa, Hugh R. A. Jones, J. Bailey, Jennifer Burt, B. D. Carter, Jeffrey D. Crane, Francesco Flammini Dotti, Bradford Holden, Bo Ma, Masahiro Ogihara, Rebecca Oppenheimer, S. J. O’Toole, Stephen A. Shectman, Robert A. Wittenmyer, Sharon X. Wang, D. J. Wright, Yifan Xuan
We analyze 5108 AFGKM stars with at least five high precision radial velocity points as well as Gaia and Hipparcos astrometric data utilizing a novel pipeline developed in previous work. We find 914 radial velocity signals with periods longer than 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df2091d05b4cff19477bd766a66be9ae
http://arxiv.org/abs/2208.12720
http://arxiv.org/abs/2208.12720
Autor:
T. Van Reeth, P. De Cat, J. Van Beeck, V. Prat, D. J. Wright, H. Lehmann, A.-N. Chené, E. Kambe, S. L. S. Yang, G. Gentile, M. Joos
The TESS space mission provides us with high-precision photometric observations of bright stars over more than 70% of the entire sky, allowing us to revisit and characterise well-known stars. We aim to conduct an asteroseismic analysis of the gamma D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166e7d459a82271df4959a4d2bca8afc
https://resolver.caltech.edu/CaltechAUTHORS:20220614-222204000
https://resolver.caltech.edu/CaltechAUTHORS:20220614-222204000
Autor:
E. I. Minder, A. J. Lloyd, G. Biolcati, D. J. Wright, P. J. Wolgen, J. H. P. Wilson, Norbert J. Neumann, S. Hanneken
Publikováno v:
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-1 (2021)
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-1 (2021)
A novel treatment has been developed for erythropoietic protoporphyria (EPP) (a rare condition that leaves patients highly sensitive to light). To fully understand the burden of EPP and the benefit of treatment, a novel patient reported outcome (PRO)